FORESEE PHARMACEUTICALS, Co LTD. – Trademark Portfolio

Entity Type: 03

FORESEE PHARMACEUTICALS, Co LTD. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 8 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include C and CAMCEVI. The owner is based in Taipei City 115.

9F-2 No. 19-3 Sanchong Nangang District

Taipei City 115 , TW

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CAMCEVI
CAMCEVI
Registered 2021
C
C
Registered 2020
SIGFYA
SIGFYA
Abandoned 2019
TYGOVY
TYGOVY
Abandoned 2018
SIGFRI
SIGFRI
Abandoned 2018
HILZAVO
HILZAVO
Abandoned 2018
CAMCEVI
CAMCEVI
Registered 2018
ONFREYO
ONFREYO
Abandoned 2018

Trademark Classifications

FORESEE PHARMACEUTICALS, Co LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (8 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does FORESEE PHARMACEUTICALS, Co LTD. have?

FORESEE PHARMACEUTICALS, Co LTD. has 8 U.S. trademarks filed with the USPTO. Of these, 3 registered, 5 abandoned.

What trademark classes does FORESEE PHARMACEUTICALS, Co LTD. file in?

FORESEE PHARMACEUTICALS, Co LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are FORESEE PHARMACEUTICALS, Co LTD.'s most well-known trademarks?

FORESEE PHARMACEUTICALS, Co LTD.'s registered trademark portfolio includes well-known marks such as C and CAMCEVI. These are among 3 currently registered trademarks in the portfolio.

What is FORESEE PHARMACEUTICALS, Co LTD.'s trademark registration success rate?

FORESEE PHARMACEUTICALS, Co LTD. has a 38% trademark registration rate, with 3 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.